Drugmaker Celgene Corp. agreed to invest an additional $30 million in a cancer-fighting start-up that’s majority owned by Los Angeles biotech entrepreneur Dr. Patrick Soon-Shiong, the companies said Friday.
Celgene’s second-round funding would raise its overall investment in NantCell to $105 million,…
Source: latimes.com – Los Angeles Times